Subscribe to Newsletter

Search

Reset Filter

149 search results for ‘mrna vaccine’

Discovery & Development Formulation

Calling All Formulation Experts

From StomachSim, to taste masking, to micronization; check out our special eBook on Formulation

Discovery & Development Ingredients

Dive into the Heart of Pharma at CPHI Milan 2024

| Sponsored by CPHi | 6 min read

CPHI Milan 2024, the premier global event for pharmaceutical professionals, will take place October 8-10 at Fiera Milano.

BioNTech

develop mRNA-based vaccines for influenza. This early work would eventually pave the way for a COVID-19 vaccine. Pfizer and BioNTech announced a letter of intent to co-develop a COVID-19 vaccine on March 17, [...] revenue in 2021: 18.9 billion euros Other recent news BioNTainer modular mRNA manufacturing solution launched to support scalable vaccine production in Africa Company has expanded collaboration with Regeneron [...] Research collaboration with Matinas BioPharma announced to evaluate novel delivery technology for mRNA vaccines Three-year collaboration announced with Medigene to develop T-cell receptor based immunotherapies

Manufacture Business Practice

Is it Time to Reevaluate Our Priorities?

| James Strachan

The COVID-19 vaccines demonstrate what’s possible when disease is tackled as a genuine priority.

Manufacture Bioprocessing - Upstream & Downstream

Combating COVID-19

| Daria Donati

Never before has the industry moved so rapidly to find new treatments and vaccines – but safety and efficacy must remain top priorities.

Manufacture Technology and Equipment

A New Definition of Versatile

| Sponsored by KNAUER | 3 min read

Looking for an adaptable screening approach for lipid nanoparticle R&D?

Marc Brown

discovery was the development of mRNA vaccines. After decades of research, rather ironically, the COVID-19 pandemic accelerated the validation of the use of mRNA in the form of vaccines for the treatment of infectious [...] regulatory authorities. This resulted in the acceleration of marketing authorizations for COVID-19 vaccines, increased knowledge of disease mechanisms, and the potential development of new mRNA-based therapies [...] immunotherapies, therapeutic protein replacement therapies, and genetic disease treatment. However, mRNA delivery itself still poses multiple challenges with regard to developing the optimal formulation/delivery

Business & Regulation Standards & Regulation

Chemistry and Humility

| Rob Coker | 3 min read

Countries that struggled to acquire COVID-19 vaccines have not forgotten the inequity, and are reminding pharma giants that they shouldn’t either

Manufacture Vaccines

Success at Speed Part 6: Logistics and Global Availability

| Piergiuseppe Nestola, Amélie Boulais

A vaccine must be able to reach patients who need it. Reliable partners and procedures are a must.

Discovery & Development Trends & Forecasts

Big Diseases in a Small World

| Seth Lederman | 5 min read

The importance of collaborative efforts in generating new vaccines to protect a vulnerable world

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register